Compare · MMM vs VVOS
MMM vs VVOS
Side-by-side comparison of 3M Company (MMM) and Vivos Therapeutics Inc. (VVOS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MMM and VVOS operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MMM is the larger of the two at $97.60B, about 33649.4x VVOS ($2.9M).
- MMM has been more active in the news (15 items in the past 4 weeks vs 11 for VVOS).
- MMM has more recent analyst coverage (25 ratings vs 1 for VVOS).
- Company
- 3M Company
- Vivos Therapeutics Inc.
- Price
- -
- -
- Market cap
- $97.60B
- $2.9M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 15
- 11
- Recent ratings
- 25
- 1
3M Company
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. 3M Company has a strategic collaboration with Merry Maids in residential cleaning sector; and collaborations with The Infectious Disease Research Institute and Duke Human Vaccine Institute to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Vivos Therapeutics Inc.
Vivos Therapeutics, Inc., a medical technology company, engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing, such as mild-to-moderate obstructive sleep apnea (OSA). Its treatment, the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of mild to moderate OSA. Vivos Therapeutics also offers VivoScore, a comprehensive home sleep apnea test. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
Latest MMM
- 3M downgraded by Wolfe Research
- The Dow Rallies Back Above a Key Average, but Five Charts Made Even Bigger Moves Today
- 3M Reaches Broad Resolution of AFFF Personal Injury Litigation
- 3M Board Approves New $6 Billion Share Repurchase Authorization, Declares Quarterly Dividend
- Meguiar’s® Reveals Ford F-100 & Aston Martin GT3 in its 2026 SEMA Booth
- EVP Chief Strategy Officer Van Wyck Jonathan G. exercised 1,501 shares at a strike of $174.34 and covered exercise/tax liability with 460 shares, increasing direct ownership by 400% to 1,302 units (SEC Form 4)
- Meguiar’s® Unleashes a Trove of New 2027 Car Care Products: Continuing 125 Years of Innovation!
- 3M and AWS collaborate to advance optical connectivity innovation
- Outside Big Tech, Tuesday's Earnings Winners Jumped as Much as 11%
- SEC Form 10-Q filed by 3M Company
Latest VVOS
- SEC Form DEFA14A filed by Vivos Therapeutics Inc.
- SEC Form DEF 14A filed by Vivos Therapeutics Inc.
- SEC Form 4 filed by Vivos Therapeutics Inc.
- SEC Form 4 filed by Vivos Therapeutics Inc.
- SEC Form 4 filed by Vivos Therapeutics Inc.
- SEC Form PRER14A filed by Vivos Therapeutics Inc.
- SEC Form 8-K filed by Vivos Therapeutics Inc.
- Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard
- SEC Form PRE 14A filed by Vivos Therapeutics Inc.
- Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel